Does this truncating variant remove a functional protein domain?
Figure: illustrative, generated to demonstrate the method
The question
Does the candidate stop-gain alter only the protein length, or does it remove a structured region needed for the protein’s proposed function?
Method
Sequence reference: MANE Select transcript Model: AlphaFold 3 prediction Domain mapping: InterPro release 101.0 Review: per-residue confidence, domain boundaries, and interface residues
What the figure shows
The predicted upstream fold is retained, while the truncation removes the C-terminal domain and several mapped interface residues. Confidence near the new terminus is lower and is not interpreted as a stable novel fold.
What follows from it
The variant is predicted to cause domain loss rather than a local structural substitution. A simple surface-residue effect and a preserved complete domain were considered and ruled out by the sequence boundary; experimental functional testing is still required.
This analysis is what a target tractability assessment delivers.
